Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Beijing Darwin Cell Biotechnology Co

Request full access

Stress-induced stem cell therapies for neurodegenerative diseases

Chaoyang District, ChinaFounded 2016Biotech & Life Sciences

About Beijing Darwin Cell Biotechnology Co

Founded in 2016, Beijing Darwin Cell Biotechnology Co., Ltd. is a biopharmaceutical company focused on developing therapies for central nervous system (CNS) diseases. The company's legal representative is Wang Yu, who also serves as Chairwoman and CEO. Wang was recognized as a "Beijing March 8th Red-Banner Holder" in 2025 for her leadership and scientific achievements.

Darwin Cell Biotechnology leverages proprietary technologies, including stress-induced stem cell technology, to address neural repair in conditions like stroke, Amyotrophic Lateral Sclerosis (ALS), and Alzheimer's disease. The company's core expertise encompasses stem cells, exosomes, and protein polymers. A key development is Aleeto (DEW001), a Class I biological drug designed for CNS diseases, which works by regulating multiple pathways such as inflammation, oxidative stress, and mitochondrial damage to promote neural regeneration. The company's business model revolves around the research, development, and eventual commercialization of these biopharmaceuticals. It collaborates extensively with academic and clinical institutions, such as the joint translational laboratory for ALS and neurorepair established with Beijing Tiantan Hospital and Capital Medical University. Darwin Cell operates three GMP-standard laboratories for R&D, clinical use, and pilot-scale process development, along with subsidiaries for biopharmaceuticals and biomedical consumables.

The company is a venture capital-backed, privately held entity. It has successfully completed multiple funding rounds, including a Series C financing round of over 200 million RMB announced in July 2025. Investors include Taiping Guofa Hehe, Beijing Shijingshan State-owned Asset Management, THG Ventures, and Red Star Macalline.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
21.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Drug Development, Neurology, Stem Cells, Degenerative Diseases, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Dec 2025 — — THG Ventures · Wuhan Optics Valley Financial Holding Group ↗
SERIES COther financing Jul 2025 $28M $110M THG Ventures ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Beijing Darwin Cell Biotechnology Co website traffic

Latest recorded traffic for Beijing Darwin Cell Biotechnology Co is 740 monthly website visits, down 8.6% over the last three months.

Latest monthly visits740 3-month web change-8.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Beijing Darwin Cell Biotechnology Co in the Chaoyang District ecosystem

Live from Dealroom

The Beijing Darwin Cell Biotechnology Co office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • National SME Development Fund
  • Jinan Lantian Investment
  • Shanghai Yungu Investment
  • Shijingshan Modern Innovation Industry Fund

Series B and later2 investors entered at this stage

  • THG Ventures
  • Wuhan Optics Valley Financial Holding Group
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Chaoyang District HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Beijing Darwin Cell Biotechnology Co on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Beijing Darwin Cell Biotechnology Co’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.